Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 425

The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.

Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development

Meier-Menches, Samuel M., Gerner, Christopher, Berger, Walter, Hartinger, Christian G., Keppler, Bernhard K.·2018·Chemical Society Reviews
DOI 10.1039/c7cs00332c
Open this paper in CoChat — free account

Abstract

The drug discovery process of ruthenium and osmium anticancer therapeutics is described, including global structure–activity relationships.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1039/c7cs00332c

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 107 references

Research works printed but not linked: 82

  1. Lay, 1991, Adv. Inorg. Chem., 37, 219, 10.1016/S0898-8838(08)60008-2 · doi:10.1016/s0898-8838(08)60008-2
  2. Ono, 2012, Oncol. Lett., 4, 905, 10.3892/ol.2012.842 · doi:10.3892/ol.2012.842
  3. Coskun, 2008, Neoplasma, 55, 65
  4. Durig, 1976, Chem.-Biol. Interact., 13, 287, 10.1016/0009-2797(76)90081-8 · doi:10.1016/0009-2797(76)90081-8
  5. Clarke, 1974, J. Am. Chem. Soc., 96, 5413, 10.1021/ja00824a016 · doi:10.1021/ja00824a016
  6. Clarke, 1978, J. Am. Chem. Soc., 100, 5068, 10.1021/ja00484a026 · doi:10.1021/ja00484a026
  7. Kelman, 1977, J. Clin. Hematol. Oncol., 7, 274
  8. Clarke, 1980, J. Inorg. Biochem., 12, 79, 10.1016/S0162-0134(00)80045-8 · doi:10.1016/s0162-0134(00)80045-8
  9. Clarke, 1980, Inorg. Chem., 19, 1103, 10.1021/ic50206a078 · doi:10.1021/ic50206a078
  10. Keppler, 1986, J. Cancer Res. Clin. Oncol., 111, 166, 10.1007/BF00400758 · doi:10.1007/bf00400758
  11. Keppler, 1987, Inorg. Chem., 26, 4366, 10.1021/ic00273a018 · doi:10.1021/ic00273a018
  12. Berger, 1989, Anticancer Res., 9, 761
  13. Dhubhghaill, 1994, J. Chem. Soc., Dalton Trans., 3305, 10.1039/DT9940003305 · doi:10.1039/dt9940003305
  14. Chatlas, 1995, Inorg. Chim. Acta, 233, 59, 10.1016/0020-1693(94)04447-4 · doi:10.1016/0020-1693(94)04447-4
  15. Smith, 1996, J. Biol. Inorg. Chem., 1, 424, 10.1007/s007750050074 · doi:10.1007/s007750050074
  16. Trynda-Lemiesz, 1999, J. Inorg. Biochem., 73, 123, 10.1016/S0162-0134(99)00004-5 · doi:10.1016/s0162-0134(99)00004-5
  17. Pieper, 1998, Analusis, 26, M84, 10.1051/analusis:1998155 · doi:10.1051/analusis:1998155
  18. Thompson, 2012, J. Clin. Oncol., 30, 3033, 10.1200/jco.2012.30.15_suppl.3033 · doi:10.1200/jco.2012.30.15_suppl.3033
  19. Monti-Bragadin, 1975, Antimicrob. Agents Chemother., 7, 825, 10.1128/AAC.7.6.825 · doi:10.1128/aac.7.6.825
  20. Alessio, 1988, Inorg. Chem., 27, 4099, 10.1021/ic00296a006 · doi:10.1021/ic00296a006
  21. Sava, 1989, Pharmacol. Res., 21, 617, 10.1016/1043-6618(89)90204-1 · doi:10.1016/1043-6618(89)90204-1
  22. Alessio, 1991, Inorg. Chem., 30, 609, 10.1021/ic00004a005 · doi:10.1021/ic00004a005
  23. Sava, 1992, Anti-Cancer Drugs, 3, 25, 10.1097/00001813-199202000-00005 · doi:10.1097/00001813-199202000-00005
  24. Sava, 1994, Drug Invest., 8, 150, 10.1007/BF03259431 · doi:10.1007/bf03259431
  25. Casini, 2010, ChemMedChem, 5, 1989, 10.1002/cmdc.201000331 · doi:10.1002/cmdc.201000331
  26. Mestroni, 1994, Metal-Based Drugs, 1, 41, 10.1155/MBD.1994.41 · doi:10.1155/mbd.1994.41
  27. Sava, 1998, Pathol. Oncol. Res., 4, 30, 10.1007/BF02904692 · doi:10.1007/bf02904692
  28. Gopal, 1999, Biochemistry, 38, 4382, 10.1021/bi981990s · doi:10.1021/bi981990s
  29. Velders, 2000, Inorg. Chem., 39, 2966, 10.1021/ic000167t · doi:10.1021/ic000167t
  30. Hotze, 2000, Inorg. Chem., 39, 3838, 10.1021/ic000066v · doi:10.1021/ic000066v
  31. Yan, 2005, Chem. Commun., 4764, 10.1039/b508531b · doi:10.1039/b508531b
  32. Allardyce, 2001, Platinum Met. Rev., 45, 62, 10.1595/003214001X4526269 · doi:10.1595/003214001x4526269
  33. Ang, 2006, Inorg. Chem., 45, 9006, 10.1021/ic061008y · doi:10.1021/ic061008y
  34. Ozaslan, 2011, Afr. J. Biotechnol., 10, 2375
  35. Bergamo, 2008, Int. J. Oncol., 33, 1281
  36. Wu, 2008, Nat. Chem. Biol., 4, 110, 10.1038/nchembio.2007.58 · doi:10.1038/nchembio.2007.58
  37. Aird, 2001, Br. J. Cancer, 85, 101
  38. Cummings, 2000, Clin. Cancer Res., 6, 4494s
  39. Guichard, 2006, Biochem. Pharmacol., 71, 408, 10.1016/j.bcp.2005.10.053 · doi:10.1016/j.bcp.2005.10.053
  40. Bergamo, 2010, J. Inorg. Biochem., 104, 79, 10.1016/j.jinorgbio.2009.10.005 · doi:10.1016/j.jinorgbio.2009.10.005
  41. Chen, 2002, J. Am. Chem. Soc., 124, 3064, 10.1021/ja017482e · doi:10.1021/ja017482e
  42. Chen, 2003, J. Am. Chem. Soc., 125, 173, 10.1021/ja027719m · doi:10.1021/ja027719m
  43. Wang, 2005, J. Biol. Inorg. Chem., 10, 147, 10.1007/s00775-004-0621-5 · doi:10.1007/s00775-004-0621-5
  44. Dorcier, 2005, Organometallics, 24, 2114, 10.1021/om049022a · doi:10.1021/om049022a
  45. Peacock, 2006, J. Am. Chem. Soc., 128, 1739, 10.1021/ja055886r · doi:10.1021/ja055886r
  46. Peacock, 2007, Inorg. Chem., 46, 4049, 10.1021/ic062350d · doi:10.1021/ic062350d
  47. Cebrian-Losantos, 2007, Inorg. Chem., 46, 5023, 10.1021/ic700405y · doi:10.1021/ic700405y
  48. Buchel, 2011, Inorg. Chem., 50, 7690, 10.1021/ic200728b · doi:10.1021/ic200728b
  49. Groessl, 2007, J. Med. Chem., 50, 2185, 10.1021/jm061081y · doi:10.1021/jm061081y
  50. Kostrhunova, 2008, J. Med. Chem., 51, 3635, 10.1021/jm701538w · doi:10.1021/jm701538w
  51. Hung, 1981, Inorg. Chem., 20, 457, 10.1021/ic50216a028 · doi:10.1021/ic50216a028
  52. S. H. van Rijt , A. F. A.Peacock and P. J.Sadler , in Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy – Molecular Mechanisms and Clinical Applications , ed. A. Bonetti , R. Leone , F. M. Muggia and S. B. Howell , Humana Press , New York , 2009 , pp. 73–79 10.1007/978-1-60327-459-3_10 · doi:10.1007/978-1-60327-459-3_10
  53. Hartinger, 2012, Organometallics, 31, 5677, 10.1021/om300373t · doi:10.1021/om300373t
  54. McKeage, 2000, Cancer Chemother. Pharmacol., 46, 343, 10.1007/s002800000166 · doi:10.1007/s002800000166
  55. Mendoza-Ferri, 2009, Organometallics, 28, 6260, 10.1021/om900715j · doi:10.1021/om900715j
  56. Serli, 2005, Eur. J. Inorg. Chem., 3423, 10.1002/ejic.200500210 · doi:10.1002/ejic.200500210
  57. Akbayeva, 2003, Chem. Commun., 264, 10.1039/b210102e · doi:10.1039/b210102e
  58. Weber, 1986, Inorg. Chem., 25, 1088, 10.1021/ic00228a007 · doi:10.1021/ic00228a007
  59. Magennis, 2007, Inorg. Chem., 46, 5059, 10.1021/ic062111q · doi:10.1021/ic062111q
  60. Hanif, 2010, Dalton Trans., 39, 7345, 10.1039/c003085f · doi:10.1039/c003085f
  61. Peacock, 2007, Chem. – Eur. J., 13, 2601, 10.1002/chem.200601152 · doi:10.1002/chem.200601152
  62. Peacock, 2007, J. Am. Chem. Soc., 129, 3348, 10.1021/ja068335p · doi:10.1021/ja068335p
  63. Schmid, 2007, Organometallics, 26, 6643, 10.1021/om700813c · doi:10.1021/om700813c
  64. Berger, 2008, Chem. – Eur. J., 14, 9046, 10.1002/chem.200801032 · doi:10.1002/chem.200801032
  65. Hanif, 2011, J. Inorg. Biochem., 105, 224, 10.1016/j.jinorgbio.2010.10.004 · doi:10.1016/j.jinorgbio.2010.10.004
  66. Kasser, 2010, J. Organomet. Chem., 695, 875, 10.1016/j.jorganchem.2010.01.007 · doi:10.1016/j.jorganchem.2010.01.007
  67. Kandioller, 2009, Organometallics, 28, 4249, 10.1021/om900483t · doi:10.1021/om900483t
  68. Kandioller, 2009, J. Organomet. Chem., 694, 922, 10.1016/j.jorganchem.2008.10.016 · doi:10.1016/j.jorganchem.2008.10.016
  69. Kandioller, 2009, Chem. – Eur. J., 15, 12283, 10.1002/chem.200901939 · doi:10.1002/chem.200901939
  70. Schmidlehner, 2016, Dalton Trans., 45, 724, 10.1039/C5DT02722E · doi:10.1039/c5dt02722e
  71. S. M. Meier , PhD thesis, University of Vienn a , 2013
  72. Klose, 2017, Analyst, 142, 2327, 10.1039/C7AN00350A · doi:10.1039/c7an00350a
  73. Mendes, 2017, Anti-Cancer Agents Med. Chem., 17, 126, 10.2174/1871520616666160922165133 · doi:10.2174/1871520616666160922165133
  74. Pernot, 2012, J. Photochem. Photobiol., B, 117, 80, 10.1016/j.jphotobiol.2012.08.012 · doi:10.1016/j.jphotobiol.2012.08.012
  75. Dickson, 2011, J. Clin. Oncol., 29, 2607, 10.1200/jco.2011.29.15_suppl.2607 · doi:10.1200/jco.2011.29.15_suppl.2607
  76. Zorzet, 2001, Metal-Based Drugs, 8, 1, 10.1155/MBD.2001.1 · doi:10.1155/mbd.2001.1
  77. Groessl, 2008, Electrophoresis, 29, 2224, 10.1002/elps.200780790 · doi:10.1002/elps.200780790
  78. Cocchietto, 2000, Pharmacol. Toxicol., 87, 193, 10.1034/j.1600-0773.2000.d01-73.x · doi:10.1034/j.1600-0773.2000.d01-73.x
  79. Yoshida, 2011, Anticancer Res., 31, 1271
  80. Guidi, 2013, J. Inorg. Biochem., 118, 94, 10.1016/j.jinorgbio.2012.10.003 · doi:10.1016/j.jinorgbio.2012.10.003
  81. Kreutz, 2017, Chem. – Eur. J., 23, 1881, 10.1002/chem.201604516 · doi:10.1002/chem.201604516
  82. Miller, Jr., 2002, Cancer Res., 62, 3893

Cited by

See all 425

Metadata

Authors
Meier-Menches, S. M., Gerner, C., Berger, W., Hartinger, C. G., & Keppler, B. K.
Venue
Chemical Society Reviews
Publisher
Royal Society of Chemistry (RSC)
Published
2018
Volume
47
Issue
3
Pages
909-928
ISSN
  • 0306-0012 (ISSN-L)
  • 1460-4744
DOI
10.1039/c7cs00332c
OpenAlex
W2770473333
Cited by
425
References
107
FWCI
4.80
Type
journal article
Language
en
Open access
closed
Licence
rsc.li/journals-terms-of-use (am, 327 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development. https://app.cochat.ai/papers/10.1039/c7cs00332c
The paper
Meier-Menches, S. M., Gerner, C., Berger, W., Hartinger, C. G., & Keppler, B. K. (2018). Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development. Chemical Society Reviews. https://doi.org/10.1039/c7cs00332c

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.